WO2023042081 - )-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
National phase entry:
Publication Number
WO/2023/042081
Publication Date
23.03.2023
International Application No.
PCT/IB2022/058641
International Filing Date
14.09.2022
Title **
[English]
)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
[French]
)-4
Applicants **
RICHTER GEDEON NYRT.
Gyömröi út 19-21.
1103 Budapest, HU
BUDAPESTI MŰSZAKI ÉS GAZDASÁGTUDOMÁNYI EGYETEM
Műegyetem rkp. 3.
1111 Budapest, HU
Inventors
FARKAS, Emese
Kossuth út 109.
3841 Aszaló, HU
POPPE, László
Szilasliget utca 3.
1172 Budapest, HU
HORNYÁNSZKY, Gábor
Szárny u. 7.
1173 Budapest, HU
INCZE, Dániel János
Kresz Géza utca 44-46. III/24
1132 Budapest, HU
ÉLES, János
Ördögszikla út 2.
1121 Budapest, HU
SÁNTA-BELL, Evelin
Bártfai u. 36. 8/26
1115 Budapest, HU
MOLNÁR, Zsófia Klára
Kovász u. 12.
1238 Budapest, HU
SZEMES, József
Juhász Gyula u. 27/A
2315 Szigethalom, HU
SCHNEIDER, Anna
Szilágyi Erzsébet u. 9.
8900 Zalaegerszeg, HU
CSUKA, Pál
Hunyadi u. 79.
2085 Pilisvörösvár, HU
Priority Data
P2100325
15.09.2021
HU
P2200363
13.09.2022
HU
Application details
Total Number of Claims/PCT | * |
Number of Independent Claims | * |
Number of Priorities | * |
Number of Multi-Dependent Claims | * |
Number of Drawings | * |
Pages for Publication | * |
Number of Pages with Drawings | * |
Pages of Specification | * |
Sequence Listing | * |
International Search Report is established | *
International Searching Authority
EPO
* |
Applicant's Legal Status |
Legal Entity
* * * * * |
Entry into National Phase under |
Chapter I
* |
Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
Country | Stages | Total | |
---|---|---|---|
China | Filing | 2668 | |
EPO | Filing, Examination | 21746 | |
Japan | Filing | 558 | |
South Korea | Filing | 611 | |
USA | Filing, Examination | 16235 |


Total: 41818 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
-4-((1,3-dioxolan-2-yl)methyl)cyclohexan-1-amine may be produced.[French]
-4-((1,3-dioxolan-2-yl)méthyl)cyclohexane-1-amine.